Review | Carcinogenesis Open Access

Cancer and stress: what’s matter? from epidemiology: the psychologist and oncologist point of view

Nerina Denaro, Letteria Tomasello, Elvio Grazioso Russi
Journal of Cancer Therapeutics & Research 3 : 6
Original Research | Organ Specific Cancers Open Access

Outcomes for critically ill patients with haematological malignancies in specialist and non-specialist centres in the United Kingdom

Peter Andrew Hampshire, Richard Pugh, Phillip Hajimichael
Journal of Cancer Therapeutics & Research 3 : 5
Original Research | Epidemiology, Genetics and Genomics Open Access

A study of incidence of EGFR mutations in non-smoker adenocarcinoma of the lung: disparity between north and south indian patients

Manish Pungliya, Minhas Sachin, Nagasamy Soumittra, Patil Shekar, Aggarwal Shyam
Journal of Cancer Therapeutics & Research 3 : 4
Original Research | Organ Specific Cancers Open Access

Are mutations in K-RAS, BRAF and PIK3CA genes critical for response to adjuvant trastuzumab treatment in patients with HER-2 positive breast cancer?

Anne Marie Bak Jylling, Anders Aamann Rasmussen, Erik Hugger Jakobsen, René dePont Christensen, Flemming Brandt Sørensen
Journal of Cancer Therapeutics & Research 3 : 3
Original Research | Organ Specific Cancers Open Access

The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer

Priyanka Sharma, Shane R. Stecklein, Bruce F. Kimler, Geetika Sethi, Brian K. Petroff, Teresa A. Phillips, Ossama W. Tawfik, Andrew K. Godwin, Roy A. Jensen
Journal of Cancer Therapeutics & Research 3 : 2
Original Research | Epidemiology, Genetics and Genomics Open Access

Apoptosis-related single nucleotide polymorphisms and the risk of non-small cell lung cancer in women

Anand Pathak, Angela S. Wenzlaff, Paula L. Hyland, Michele L. Cote, Greg R. Keele, Susan Land, Matthew L. Boulton, Ann G. Schwartz
Journal of Cancer Therapeutics & Research 3 : 1
Original Research | Innovative Therapies Open Access

PCI-24781 (abexinostat), a novel histone deacetylase inhibitor, induces reactive oxygen species-dependent apoptosis and is synergistic with bortezomib in neuroblastoma

Giselle Saulnier Sholler, Erika A. Currier, Akshita Dutta, Marni A. Slavik, Sharon A. Illenye, Maria Cecilia F. Mendonca, Julie Dragon, Stephen S. Roberts, Jeffrey P. Bond
Journal of Cancer Therapeutics & Research 2 : 21
Review | Innovative Therapies Open Access

Membranes, molecules and biophysics: enhancing monocyte derived dendritic cell (MDDC) immunogenicity for improved anti-cancer therapy

Cyril Rauch, Hiba Ibrahim, Neil Foster
Journal of Cancer Therapeutics & Research 2 : 20
Original Research | Innovative Therapies Open Access

Massive induction of apoptosis of multicellular tumor spheroids by a novel compound with a calmodulin inhibitor-like mechanism

Chitralekha Mohanty, Walid Fayad, Maria Hägg Olofsson, Rolf Larsson, Angelo De Milito, Mårten Fryknäs, Stig T Linder
Journal of Cancer Therapeutics & Research 2 : 19
Original ResearchOpen Access

Rat C6 glioma cell motility and glioma growth are regulated by netrin and netrin receptors unc5B and DCC

Margaret Durko, Zaf Koty, Lixia Zhu, Nathalie Marçal, Timothy E. Kennedy, Josephine Nalbantoglu
Journal of Cancer Therapeutics & Research 2 : 18

Cancer Stem Cells

Journal of Cancer Therapetics & Research Open access Journal covers special section Cancer stem cells aims to publish research on identification, characterization and isolation of cancer stem cells in various cancer types, metastatic mechanisms, surface markers and their role in cancer initiation, progression and maintenance. The scope of the section includes reviews, hypothetical theories, clinical practices and novel techniques in regulating cancer stem cells.

Innovative Therapies

Journal of Cancer Therapetics & Research Open access Journal covers special section Innovative Therapies focuses on the treatment and prevention of cancer. This section inculdes cancer curing therapies and pharmaceutical applications with the study of anti-cancer drugs, therapeutic agents and Drug Development based on the signalling mechanisms and pharmacodynamics.

Carcinogenesis

Journal of Cancer Therapetics & Research Open access Journal contains special section Carcinogenesis covers the study of cells undergoing carcinogenesis with uncontrolled mutagenesis. It includes every aspect of biochemical mechanisms in relation to the cancer development. Also the focus is on medicinal research from diagnostic testing to monitoring of tumor progression through modulating agents and molecular epidemiology, examination of cells and tissues.

Organ Specific Cancers

Journal of Cancer Therapetics & Research Open access Journal covers special section Organ Specific Cancers, With its heterogenetic ability, Cancer has a diversified nature in relation to the organ specificity. This section encompasses study of cancer dvelopment in different organs and their transition among the organs. The primary focus is on heterogeneity, origin, metastasis, angiogenesis and organ specified mechanisms in cancer cells.

Radiation And Imaging

Journal of Cancer Therapetics & Research Open access Journal covers special section Radiation and Imaging section includes medical diagnostic procedures and treatment using radiation, chemotherapy and imaging technology. It focuses on the modified therapeutic strategies to control cancer and implementing preventional methods.

Epidemiology, Genetics And Genomics

Journal of Cancer Therapetics & Research Open access Journal covers special section Epidemiology Genetics and Genomics aim to attract papers in the field of epidemiology, genetics and genomics in cancer cells and cancer patients. Understanding the cancer genetics, gene expression and regulation in cancer cells, their heterogeneity will give new insights in diagnosis and treatment. The section intend to disseminate information and knowledge that may furnish novel applications such as personalized treatment with either DNA or protein kinase targeted drugs, combinations with modern radiotherapeutic approaches. The section also considers studies performing whole genome sequencing to recognize potential drug targets or limited for selected genes to identify patients responding to particular treatments more likely.